JP2009508902A5 - - Google Patents

Download PDF

Info

Publication number
JP2009508902A5
JP2009508902A5 JP2008531609A JP2008531609A JP2009508902A5 JP 2009508902 A5 JP2009508902 A5 JP 2009508902A5 JP 2008531609 A JP2008531609 A JP 2008531609A JP 2008531609 A JP2008531609 A JP 2008531609A JP 2009508902 A5 JP2009508902 A5 JP 2009508902A5
Authority
JP
Japan
Prior art keywords
formula
alkyl
compound
iif
iie
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2008531609A
Other languages
English (en)
Japanese (ja)
Other versions
JP2009508902A (ja
Filing date
Publication date
Priority claimed from EP05020508A external-priority patent/EP1764095A1/en
Application filed filed Critical
Publication of JP2009508902A publication Critical patent/JP2009508902A/ja
Publication of JP2009508902A5 publication Critical patent/JP2009508902A5/ja
Pending legal-status Critical Current

Links

JP2008531609A 2005-09-20 2006-09-20 セレクチンリガンド活性を有する新規なニトロカテコール誘導体 Pending JP2009508902A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP05020508A EP1764095A1 (en) 2005-09-20 2005-09-20 Novel nitrocatechol derivatives having selectin ligand activity
PCT/EP2006/009155 WO2007039114A1 (en) 2005-09-20 2006-09-20 Novel nitrocatechol derivatives having selectin ligand activity

Publications (2)

Publication Number Publication Date
JP2009508902A JP2009508902A (ja) 2009-03-05
JP2009508902A5 true JP2009508902A5 (cg-RX-API-DMAC7.html) 2009-11-12

Family

ID=35892515

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2008531609A Pending JP2009508902A (ja) 2005-09-20 2006-09-20 セレクチンリガンド活性を有する新規なニトロカテコール誘導体

Country Status (10)

Country Link
US (2) US7851501B2 (cg-RX-API-DMAC7.html)
EP (2) EP1764095A1 (cg-RX-API-DMAC7.html)
JP (1) JP2009508902A (cg-RX-API-DMAC7.html)
CN (2) CN101374508B (cg-RX-API-DMAC7.html)
AU (1) AU2006299184B8 (cg-RX-API-DMAC7.html)
BR (1) BRPI0616391A2 (cg-RX-API-DMAC7.html)
CA (1) CA2622935A1 (cg-RX-API-DMAC7.html)
IL (1) IL190157A0 (cg-RX-API-DMAC7.html)
RU (1) RU2428979C2 (cg-RX-API-DMAC7.html)
WO (1) WO2007039114A1 (cg-RX-API-DMAC7.html)

Families Citing this family (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6838452B2 (en) * 2000-11-24 2005-01-04 Vascular Biogenics Ltd. Methods employing and compositions containing defined oxidized phospholipids for prevention and treatment of atherosclerosis
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
EP1764094A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel multi-cyclic compounds and their use
EP1764093A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764095A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
EP1764096A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
BRPI0717511A2 (pt) * 2006-09-29 2013-11-19 Idenix Pharmaceuticals Inc Composto puro, composição farmacêutica, métodos para tratar uma infecção por hiv, para prevenir uma infecção por hiv, para inibir a replicação de hiv, e, uso de um composto
DE102007018151A1 (de) * 2007-04-16 2008-10-23 Günenthal GmbH Neue Vanilloid-Rezeptor Liganden und ihre Verwendung zur Herstellung von Arzneimitteln
EA015952B1 (ru) 2007-05-03 2011-12-30 Пфайзер Лимитед 2-пиридинкарбоксамидные производные в качестве модуляторов натриевых каналов
US8293747B2 (en) * 2007-07-19 2012-10-23 Merck Sharp & Dohme Corp. Heterocyclic amide compounds as protein kinase inhibitors
JP5555166B2 (ja) * 2008-08-29 2014-07-23 サントリーホールディングス株式会社 新規エピガロカテキンガレート３量体、およびエピガロカテキンガレート重合体を含むα−グルコシダーゼ阻害剤
US8450357B2 (en) * 2008-11-19 2013-05-28 Merial Limited Compositions comprising an aryl pyrazole and/or a formamidine, methods and uses thereof
TWI432188B (zh) * 2008-12-19 2014-04-01 Merz Pharma Gmbh & Co Kgaa 供治療發炎性皮膚疾病之１－胺基－烷基環己烷衍生物類
US8399519B2 (en) 2008-12-19 2013-03-19 Merz Pharma Gmbh & Co. Kgaa 1-amino-alkylcyclohexane derivatives for the treatment of mast cell mediated diseases
US8557805B2 (en) * 2008-12-29 2013-10-15 Takeda Pharmaceutical Company Limited Fused ring compound and use thereof
US8366791B1 (en) 2011-09-02 2013-02-05 Warner Babcock Institute Formulation and method for hair dyeing
US8569372B2 (en) * 2011-09-27 2013-10-29 Hsiao-Ming Chao Method for preventing or treating a disease, disorder or condition induced by retina ischemia
US8828100B1 (en) 2013-10-14 2014-09-09 John C. Warner Formulation and processes for hair coloring
CN116617195A (zh) * 2015-01-22 2023-08-22 米托充制药公司 脑源性神经营养因子的诱导表达
CA3109798A1 (en) 2018-08-17 2020-02-20 The Trustees Of The University Of Pennsylvania Compositions and methods for treatment of acute lung injury

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4363813A (en) * 1979-07-09 1982-12-14 Kureha Kagaku Kogyo Kabushiki Kaisha 2-(3,4,5-Trimethoxyphenyl)-4,5-disubstituted thiazoles
JPS58156932A (ja) * 1982-03-11 1983-09-19 Fuji Photo Film Co Ltd ハロゲン化銀カラ−写真感光材料
US4757084A (en) 1984-02-29 1988-07-12 Merck & Co., Inc. 2,5-diaryl tetrahydrothiophenes and analogs thereof as PAF-antagonists
GB2238047B (en) 1989-11-03 1993-02-10 Orion Yhtymae Oy Stable polymorphic form of (e)-n,n-diethyl-2-cyano-3-(3,4-dihydroxy-5-nitrophenyl)acrylamide and the process for its preparation
EP0465122A1 (en) 1990-06-29 1992-01-08 Merck & Co. Inc. Process of making 2,5-diaryl tetrahydrofurans and analogs thereof useful as paf antagonists
US5374772A (en) * 1992-12-08 1994-12-20 Hoffmann-Laroche Inc. Substituted benzoic acids, inhibitors of phospholipases A2
US5444050A (en) 1994-04-29 1995-08-22 Texas Biotechnology Corporation Binding of E-selectin or P-selectin to sialyl Lewisx or sialyl-Lewisa
BR9609285A (pt) 1995-06-29 1999-05-11 Novartis Ag Dióis-1,2 diglicosilados como miméticos do sialil-lewis x e do sialil-lewis a
FI974618A7 (fi) 1995-06-29 1997-12-23 Texas Biotechnology Corp Kahden- ja kolmenarvoiset pienimolekyyliset selektiininestäjät
DE19532902A1 (de) * 1995-09-06 1997-03-13 Hoechst Ag Neuartige Glycomimetika als Selektin-Antagonisten und daraus hergestellte entzündungshemmend wirkende Arzneimittel
EP0883574B1 (en) * 1996-03-01 2004-01-02 Dionex Corporation Anion-exchange resins with at least two different nitrogen containing ion-exchange groups
FR2761066B1 (fr) * 1997-03-24 2000-11-24 Sod Conseils Rech Applic Nouveaux derives du 2-(iminomethyl)amino-phenyle, leur preparation, leur application a titre de medicaments et les compositions pharmaceutiques les contenant
AU1804299A (en) 1997-12-08 1999-06-28 Glycomed Incorporated Sialyl lewis x and sialyl lewis a glycomimetics
WO1999029706A2 (en) 1997-12-08 1999-06-17 Glycomed Incorporated DISALICYLATE ANALOG BASED SIALYL LEWISx MIMETICS
AU2039800A (en) 1998-12-04 2000-06-26 Ontogen Corporation 5-membered heterocycles for the treatment of human diseases involving modulatorsof selectins
GB2344819A (en) * 1998-12-18 2000-06-21 Portela & Ca Sa 2-Phenyl-1-(3,4-dihydroxy-5-nitrophenyl)-1-ethanones
US6248790B1 (en) 2000-06-29 2001-06-19 Parker Hughes Institute Treatment of inflammation with 2,4,6-trihydroxy-alpha-rho-methoxyphenylacetophenone, or its pharmaceutically acceptable derivatives
US6432957B1 (en) * 2001-06-29 2002-08-13 Kowa Co., Ltd. Piperazine derivative
WO2003009807A2 (en) * 2001-07-23 2003-02-06 Galileo Laboratories, Inc. Cytoprotective compounds, pharmaceutical and cosmetic formulations, and methods
JP2003055369A (ja) 2001-08-06 2003-02-26 Univ Nihon 新規なフロログルシノール誘導体、及びこれを用いた組成物、抗アレルギー剤
WO2003075905A1 (es) 2002-03-14 2003-09-18 Bobel 246, S.L. Uso de derivados de fenoles 2,4-disubstituidos como inhibidores de la expresion de l-selectinas y de la isoforma inductible de la sintasa del oxido nitrico
AU2002244906A1 (en) * 2002-03-27 2003-10-08 Council Of Scientific And Industrial Research Formation of neolignan by ddq mediated dimerisation of dihydroasarone
WO2003097658A2 (en) 2002-05-16 2003-11-27 Glycomimetics, Inc. Compounds and methods for inhibiting selectin-mediated function
EP1527086B1 (en) 2002-08-09 2008-01-09 Astellas Pharma Europe B.V. Compounds binding to p-selectin
CA2510471A1 (en) * 2002-12-19 2004-07-08 Neurogen Corporation Substituted biphenyl-4-carboxylic acid arylamide analogues as capsaicin receptor modulators
US20060188557A1 (en) 2003-05-23 2006-08-24 Hisamitsu Pharmaceutical Co., Inc. Prepartaion for external percutaneous administration containing non-steroidal anti-inflammatory drug and interleukin-1 alpha production inhibitor
EP1481669A1 (en) * 2003-05-30 2004-12-01 Yamanouchi Pharmaceutical Co. Ltd. Use of polyhydroxy phenols and polyphenols for modulating p-selectin activity
DE602004011272T2 (de) * 2003-11-19 2008-12-24 Glycomimetics, Inc. Spezifischer antagonist sowohl für e- als auch p-selektine
EP1577289A1 (en) * 2004-03-18 2005-09-21 Revotar Biopharmaceuticals AG Non-glycosylated/-glycosidic/-peptidic small molecule selectin inhibitors for the treament of inflammatory disorders
EP1764095A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel nitrocatechol derivatives having selectin ligand activity
EP1764096A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel phloroglucinol derivatives having selectin ligand activity
EP1764093A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel aromatic compounds and their use in medical applications
EP1764094A1 (en) * 2005-09-20 2007-03-21 Revotar Biopharmaceuticals AG Novel multi-cyclic compounds and their use

Similar Documents

Publication Publication Date Title
JP2009508902A5 (cg-RX-API-DMAC7.html)
ES2741439T3 (es) Compuestos aromáticos sustituidos
JP2009084270A5 (cg-RX-API-DMAC7.html)
NL8002370A (nl) Esters van acyl-carnitinen, werkwijzen ter bereiding ervan en farmaceutische preparaten, die dergelijke esters bevatten.
JP2009536191A5 (cg-RX-API-DMAC7.html)
CN102079703B (zh) 一种非甾体抗炎药制备方法及其抗炎镇痛作用
RU2008115464A (ru) Новые производные нитрокатехола, обладающие активностью в качестве лигандов селектина
JP2015519322A5 (cg-RX-API-DMAC7.html)
JP2020529988A5 (cg-RX-API-DMAC7.html)
US9296678B2 (en) Injectable formulation for treatment and protection of patients having an Inflammatory Reaction or an Ischemia-reperfusion event
JP2011046708A5 (cg-RX-API-DMAC7.html)
JP2014511897A5 (cg-RX-API-DMAC7.html)
RU2008115434A (ru) Новые производные флороглюцина, обладающие активностью в отношении лиганда селектина
JP6952911B2 (ja) ２−（αヒドロキシペンチル）安息香酸の有機アミンエステル誘導体薬物
CN104356038A (zh) 维生素d2与d3的共晶及其制备方法和用途
CN114920743A (zh) 一种吲哚生物碱及其制备方法与应用
RU2008115491A (ru) Новые полициклические соединения
CN108218814A (zh) 靶向sirt3激动剂及其在aml治疗药物中的应用
CN103483282B (zh) 苯基取代的三唑酰胺类化合物及用途
JP2013503170A5 (cg-RX-API-DMAC7.html)
TWI892182B (zh) 吡唑化合物、製備方法、其醫藥組合物及其用途
CN119039147B (zh) 一种含氟长链化合物、其自组装结构、其制备方法及其用途
CN115594686B (zh) 一类millpuline A衍生物及其制备方法和医药用途
CN107056819B (zh) 一种预防和治疗心肌缺血的药物及其制备方法
CN103467398B (zh) 三唑酰胺类化合物、其制备方法和其抗糖尿病用途